Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Swedish Discovery Firms Merge, Secure US$15.5M In Financing

Jan. 23, 2002

By Cormac Sheridan

Rhein Biotech Plans Filing This Year For Two-Dose HBV Vaccine

Jan. 16, 2002

By Cormac Sheridan

Rhein Biotech Plans Filing This Year For Two-Dose HBV Vaccine

Jan. 16, 2002

By Cormac Sheridan

ThromboGenics Raises US$12.8M For Cardio, Stem Cell Programs

May 16, 2001

By Cormac Sheridan

Genmab, Roche Collaborate To Develop Antibody Products

May 16, 2001

By Cormac Sheridan

ThromboGenics Raises US$12.8M For Cardio, Stem Cell Programs

May 16, 2001

By Cormac Sheridan

Genmab, Roche Collaborate To Develop Antibody Products

May 16, 2001

By Cormac Sheridan

NeuroSearch Pays US$3.5M In Stock For Genomics Company

March 28, 2001

By Cormac Sheridan

NeuroSearch Pays US$3.5M In Stock For Genomics Company

March 28, 2001

By Cormac Sheridan

Modex Plans To Move EPO Cell Therapy Into Phase II

March 21, 2001

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...